Table 3.
Representative clinicals of microorganisms in pancreatic cancer.
NCT Number | Title | Study Type | Intervention | Recruitment Status | Estimated Enrollment |
---|---|---|---|---|---|
NCT03809247 | Microbial Diversity of Pancreatic Diseases | Observational | Not provided | Not yet recruiting | 330 |
NCT04274972 | The Microbiome of Pancreatic Cancer: "PANDEMIC" Study | Observational [Patient Registry] | specimen collection | Recruiting | 20 |
NCT03302637 | Oral Microbiome and Pancreatic Cancer | Observational | 16S rRNA gene sequencing assay | Completed | 735 |
NCT03891979 | Gut Microbiome Modulation to Enable Efficacy of Checkpoint-based Immunotherapy in Pancreatic Adenocarcinoma | Interventional | Drug | Withdrawn | 25 |
NCT03785210 | Refractory Primary Hepatocellular Carcinoma or liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers | Interventional | Drug | Recruiting | 27 |